Company Active PLC

Company profile

Bayer Public Limited Company

Bayer Public Limited Company is a UK company with status active founded in 1968 based in South East England.

CRN
00935048
Founded
1968
Age
58

Overview

Legal name
BAYER PUBLIC LIMITED COMPANY
Region
South East England
Registered address
400 SOUTH OAK WAY
READING
BERKSHIRE
ENGLAND
RG2 6AD
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 2 ultimate controllers Controls 13
1
Company Active PLC
Bayer Public Limited Company
CRN 00935048
2
Direct and ultimate controller
51490986
CRN 51490986
3
Direct and ultimate controller
HRB 48248
CRN HRB 48248

Company events

Reference milestones and recent Companies House filing stream events.

8 events
30 Jun
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

03 Jul
2026

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzUyNzQ5MjYyN2FkaXF6a2N4 | Paper/PDF filed

Published 06 Jul 2026 23:05

30 Jun
2026

Accounts due

Accounts Due

Next accounts due date

22 Jun
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUyNzc5OTI3NmFkaXF6a2N4

Published 22 Jun 2026 15:37

16 Jun
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

24 Feb
2025

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ1NjExNDcxNmFkaXF6a2N4

Published 24 Feb 2025 09:12

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

08 Jul
1968

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2008
Funded years
2008, 2024
Age at first award
40 years

Projects

2024 Collaborative R&D

Accelerating trustworthy AI in radiology: scalable software for clinical users to independently validate commercial products at local sites

1 Apr 2024 to 31 Mar 2025

Awarded
£77,153
Total cost £154,306

In this collaborative proposal, the Aival Analysis Lab will be used to evaluate commercial radiology AI products on imaging data representative of a broad Scottish population. We will consider two clinical treatment pathways in line with NHS Scotland service and procurement priorities: stroke triage and urgent suspicion of lung cancer triage, assessing at...

2008 Collaborative R&D

PURPOSE - Plastic UV Radiation Protection Operating by Stokes Emission

1 Sep 2008 to 30 Nov 2012

Awarded
£0
Total cost £50,256

This project will develop a range of novel polymer additives that are able to downconvert UV light to other parts of the electomagnetic spectrum, by incorporating phosphor particles into the polymers. By down converting the UV and visible (blue and green) light into red and near infra -red, these materials will be longer lasting (not be degraded by UV lig...

Product types

Collaborative R&D